Member Info for Dicko80

3.29 paid

Https://ibb.co/XxV8tkWB

Stuck a FOK order in

Yes been tricky to buy at times , they even dropped the bid yesterday to try and spook a few but then realised not a chance !

Seems lack of shares available, so should start to price in some near term deal but at £5m , long way to go

Back in 0..20s will signal “buy” on charts so expect increase in volume with positions taken

2 months ago..

https://www.lse.co.uk/rns/NFX/16310-million-placing-5eew9ksays6jy2k.html

In particular, the net proceeds will be used to fund a focused programme of additional pre-clinical studies to reinforce areas identified during ongoing out-licensing discussions and due diligence with both large pharmaceutical and speciality pharma partners, and to further advance the NXP002 programme. Whilst completion of the focused studies will represent important value inflection points for the NXP002 programme it is not expected that all the studies will need to conclude for an out-licensing or collaborative development transaction to COMPLETE .”

Company literature

Slide 16

£61.5m upfront

hTTps://nuformix.com/app/uploads/2022/11/Nuformix-Non-Confidential-Corporate-Summary-November-QA-Final-v2.pdf

Mkt cap £4m

When you consider NFX came to market with a reverse takeover of Leverett plc at a price of £12m

Now NPX002 is Derisked with ODD in Europe and USA

Mkt cap just £4m

https://www.lse.co.uk/rns/NFX/confirmation-of-european-odd-for-nxp002-tngnnmz9652p34a.html

https://www.lse.co.uk/rns/NFX/confirmation-of-us-odd-for-nxp002-in-ipf-bpbb63uz8nuerlt.html

Market Exclusivity: Provides 10 years of market exclusivity in the EU and seven years in the US upon approval, protecting NXP002 from competitors.

Regulatory Support & Incentives: Includes protocol assistance (scientific advice on clinical trial design) from regulators, reduced regulatory fees, and potential tax credits for clinical trial costs.

Validation of Asset: The positive opinion from regulatory bodies serves as independent validation of NXP002's scientific rationale, enhancing its value.

Licensing Advantage: The ODD status significantly strengthens Nuformix's position in ongoing licensing discussions, making NXP002 more attractive to potential pharmaceutical partners.

Faster Development Paths: The designation is designed to accelerate the development of treatments for rare, life-threatening diseases, helping Nuformix bring its novel inhaled treatment to patients

Page 29 valuation

Bottom paragraph

global sales deal $360 - 450m

https://nuformix.com/app/uploads/2021/06/Allenby-Initiation-Note-March-2021.pdf

Recent deal 99m upfront

https://www.fiercebiotech.com/biotech/eli-lilly-pushes-pulmonary-fibrosis-99m-deal-mediars-midphase-prospect

£4m mkt cap

Worth positioning now ODD is in place

Numbers are HUGE

£4m mkt cap

I’ve shorted it many times

Think could head to 0.55p in anticipation of a deal

https://ibb.co/YBG1Wh7x

Yesterday morning @ 0.18 then when it went to 0.19

Just noticed others commented similar on here yesterday

Make or break time looking at the chart

I noticed it was difficult to buy yesterday for even small amounts

Https://nation.africa/kenya/news/kenya-shifts-to-value-addition-in-mining-push-5439844

“Co-ordinated Pumpky”

Deary me

Give your heads a wobble

Https://ibb.co/whjYLrQ1

Im here Dukey… where are you ?

I know you are easily fooled …

But don’t let the sp fool you 🤨🤔

You can sell 2% of the company online 😉

https://ibb.co/KxzBRt40

🤩🤩🤩

I’d be surprised if they’ve gone after any onshore blocks

“Next placing Duke this weekend 2.5bn shares at 0.015p to raise 375k. A month's running costs.”

Are you an insider ?

Https://www.facebook.com/ADESDrilling/posts/we-are-proud-to-announce-the-successful-completion-of-the-onboarding-session-for/1350621747096194/

Addax is the client

JA failed again

They don’t need anymore blocks , they need to get past “go” for thali

A considered view

Jv 1 - sign off

Jv1 - funding $21m

Jv2 - DD completed

Arbitration - completion

Whilst you don’t want to see what’s in front of your eyes , anyone of potential 3 could be concluding in DRC

Https://x.com/i/status/2046239559449493563